BBR Partners LLC Purchases New Holdings in Grail, Inc. (NASDAQ:GRAL)

BBR Partners LLC purchased a new stake in Grail, Inc. (NASDAQ:GRAL) during the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 50,001 shares of the company’s stock, valued at approximately $893,000. BBR Partners LLC owned approximately 0.15% of Grail at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. FNY Investment Advisers LLC purchased a new position in Grail in the 4th quarter worth approximately $26,000. Lindbrook Capital LLC purchased a new position in Grail in the 4th quarter worth approximately $28,000. New York State Common Retirement Fund purchased a new position in Grail in the 4th quarter worth approximately $59,000. Wilmington Savings Fund Society FSB purchased a new position in Grail in the 4th quarter worth approximately $64,000. Finally, Manchester Capital Management LLC purchased a new position in Grail in the 4th quarter worth approximately $123,000.

Grail Stock Performance

Shares of NASDAQ GRAL opened at $33.45 on Friday. The company has a 50 day simple moving average of $30.38 and a 200-day simple moving average of $20.69. Grail, Inc. has a 1 year low of $12.33 and a 1 year high of $63.99.

Grail (NASDAQ:GRAL) last announced its quarterly earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($4.41) by $2.55. The firm had revenue of $38.25 million for the quarter, compared to analyst estimates of $35.33 million. On average, analysts anticipate that Grail, Inc. will post -15.15 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on GRAL. Morgan Stanley began coverage on shares of Grail in a research note on Wednesday, November 27th. They issued an “equal weight” rating and a $16.00 target price on the stock. Wolfe Research assumed coverage on shares of Grail in a report on Friday, November 15th. They set a “peer perform” rating for the company.

Grail Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.